Found: 14
Select item for more details and to access through your institution.
LXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 3, p. 1, doi. 10.1038/s41419-019-1345-3
- By:
- Publication type:
- Article
SLC39A8/Zinc Suppresses the Progression of Clear Cell Renal Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.651921
- By:
- Publication type:
- Article
RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma.
- Published in:
- International Journal of Oncology, 2019, v. 55, n. 3, p. 645, doi. 10.3892/ijo.2019.4849
- By:
- Publication type:
- Article
Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma.
- Published in:
- International Journal of Oncology, 2018, v. 53, n. 1, p. 137, doi. 10.3892/ijo.2018.4384
- By:
- Publication type:
- Article
Overexpression of SOX4 promotes cell migration and invasion of renal cell carcinoma by inducing epithelial-mesenchymal transition.
- Published in:
- International Journal of Oncology, 2017, v. 51, n. 1, p. 336, doi. 10.3892/ijo.2017.4010
- By:
- Publication type:
- Article
Melatonin/PGC1A/UCP1 promotes tumor slimming and represses tumor progression by initiating autophagy and lipid browning.
- Published in:
- Journal of Pineal Research, 2019, v. 67, n. 4, p. N.PAG, doi. 10.1111/jpi.12607
- By:
- Publication type:
- Article
Tumor Cell "Slimming" Regulates Tumor Progression through PLCL1/UCP1-Mediated Lipid Browning.
- Published in:
- Advanced Science, 2022, v. 9, n. 14, p. 1, doi. 10.1002/advs.202202011
- By:
- Publication type:
- Article
Tumor Cell "Slimming" Regulates Tumor Progression through PLCL1/UCP1‐Mediated Lipid Browning.
- Published in:
- Advanced Science, 2019, v. 6, n. 10, p. N.PAG, doi. 10.1002/advs.201801862
- By:
- Publication type:
- Article
Overall survival and cancer-specific survival were improved in local treatment of metastatic prostate cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1130680
- By:
- Publication type:
- Article
Overexpression of RACGAP1 by E2F1 Promotes Neuroendocrine Differentiation of Prostate Cancer by Stabilizing EZH2 Expression.
- Published in:
- Aging & Disease, 2023, v. 14, n. 5, p. 1757, doi. 10.14336/AD.2023.0202
- By:
- Publication type:
- Article
Upregulation of MIAT Regulates LOXL2 Expression by Competitively Binding MiR-29c in Clear Cell Renal Cell Carcinoma.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 48, n. 3, p. 1075, doi. 10.1159/000491974
- By:
- Publication type:
- Article
ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3.
- Published in:
- Theranostics, 2021, v. 11, n. 2, p. 841, doi. 10.7150/thno.49384
- By:
- Publication type:
- Article
Long noncoding RNA SNHG12 indicates the prognosis of prostate cancer and accelerates tumorigenesis via sponging miR‐133b.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 2, p. 1235, doi. 10.1002/jcp.29039
- By:
- Publication type:
- Article
The identification of new biomarkers for bladder cancer: A study based on TCGA and GEO datasets.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 9, p. 15607, doi. 10.1002/jcp.28208
- By:
- Publication type:
- Article